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Rest and tilt ANP and BNP were olgniflcantly increesed tn DO vs  HV but 
not as much as in SD. ANP and BNP increased (p .~ 0,001) with exert. ~o 
in I!11 gfouDg, "rt~m was a modest relationship (r = 0,36, p -~ 0,05) bet~n 
BNP end exercise capacity (VO2mes) for OD I~ttk0n~ I:~ no mteti~Yt::,tp 
with ANP, 
C~-~=,.~ott: Eldedy patief~ with heat1 failure due to t:haltO~tc o~tun¢. 
tlon have eb~o~mal neuroendocnne function. Thin may play a role in 
I~n~d~ of ~c ise  ~nt~Io~,Jce in such ~t ler~.  
• r.,ontpmlWe Heart Fmllum In I~  Community: 
l~ ln~ In Im:ldm~:e Ind  8urvlvM Ovor 110-Year 
M Seem, CM, l"ntx~]loy, RJ, R ~ ,  J,M Evae~, S J, ~ ,  
KR, Bad~f, M,M Red~d- A4~fo C/in~ R'Jchest~, A4W, USA 
Th~ imp~'t o! a~ano~ m th~ ~ of can~ ~ on 1~e mo- 
demce (INC) o4 ( m ~  hMzl ~ (CHF) m I~e o~m1~y m t reks .  
L i~,  ~t m tmd~z w l~Hhe av~a~l~ at ACE ~ has i ~  
(SUR) in pls w(th CHF in tho ¢¢~mLm~y We ¢on~samd the INC at 
CHF and SUR in p!~ w~l  CHF in Re~hmm~, MNm lt~11 tO that ~ m 
~,  Um~ mo ~ Sp*demek~ ~ ,  we ~ aa p~s w.h a 
Itmt d~ ol CHF ( F ~  ~ )  m 1~1 (n = 107) ~ 1991 in = t41). 
M¢lest i~we~eldedy  amlttm mea~ ~e 1 75.0 .t. 14,7m 1~B1 and 77.4 ± 
11.7 ~ m 1~1 (ns). Tho 1ffi)1 i~  tram leu  ~ (NYHA Clas~ 27  
* 0.? vs. 3.2 ± t.4, p < 0.00t). INC ~ (pe~ 1,(~0 ~ )  adiusted 
Io~ age and sex to tho US popt~t~rt and SUR were; 
tNCM~ tNC Wome~ tNC~ t-~r SUR 5-1~' SU~ 
t04BI 37 z 1~,55 21 :029 2 8 :=: 0,~i T'Z% 34% 
1991 3L7" ¢ O.S ~6 ± O~ 30 ± 02~ 77~ ~0 
Neiffte~ INC no~ SUR acrlusted tour age, m a~l  NYHA Clas~ were ddtemm 
m 1981 vs. 1991./t~ room I~s who ¢le~'e~0~ CHF me e~Md~, U~ stabte INC 
el CHF m tho commmUty ~ mmgt m increasing prevalence ol CHF as me 
ixN)uMbon ages. De~pte the pm~m be~eM of ACE mhd~k~rs Ic, r CHF, SUR 
ol lhese ek:Mdy CHF pls m Ule communety ~s not bett~ m I1'~ "ACE mly, l~m 
efa~ 
tmpact of Cdtk~ PaUmay on me mmagemem at 
Acute M ~ I  ;,~;~,~;~n i me Eldedy 
RH. I~ohta. S_ Des. E. Nolan. G Keady. 0. Karmate. P Rus~tan. 
K. Sara~ J. Nckms, K_A. Eagle. Dn~s;On of CareeoZo~. Un~emty at 
MK~Ja~ Ann Ad~;M/, USA 
Bac~gmcmd: Eldedy patsems (PTS) may mcewe sub-.ol~mal care for acute 
myoca~al ~ (AMI). These ~r~tude tess use of ~ ff'mrapy and 
mvas~e i:~rocedums. In oedm to ensure ap~,c3nale cam m air age groups. 
we eslabJished a cnbcal part,ray fo~ ~ealment of AMI, based on fl~e ha- 
bonaz gc.de-~as. ,.',e~t o~,~,.,,:ed ~ey besptaz and dmchaege U'mrapms known 
to tmpem,,e outcomas after m~al management ot AML We examine here ffm 
ulN~qct ot adllem.nce to tt,s tool m dmemnt age 91roups. 
Methods: AMI aocounted for 540 ~,s~hazgas between 3Rt5 to 2/97 (mean 
age--62 y~; mates 362; tamales 178;). T h e ~  were detined as c~c~ to 
improve PTS outcomes: beta-blockers (BB); ace mhibitors (ACEi); avo~a~e 
ol calcium b/ockers (CB); lipid Iowenng agents (LPA); outpabent mhabtrttatmn 
(OR); smoking cassat~on (SC) and diet counseling (DC). 
Resu/fs: 
AGE N BB% ASA% ACE% CCB% LPA% 
~65 306 .<Fa.3 97.3 91 92.4 68 
65-80 195 93.7 984 8 ~' 89 2 63 
~80 39 90.9 100 86 91 2 43 
p - 0 44 046 O 41 050 0 03 
AGE SC% DC% OR% CATH% PTCA% 
~6S 95.7 97.3 79.4 79.8 553 
65-80 88.1 94.1 63.1 80.0 55,4 
-.80 0 (n = 1) 97L2 64.5 73.7 444 
p 0001 0.21 0.001 082 0.67 
• RI¢ I l l  Olffofoncel In RolponIo to ~ OlockM 
Therlpy in Elderly Patkmts Sufferln9 Acute 
Myocardial Inhlrctlon 
D. Will.ires, KS K,m, E, ,~iwa~yi, S Jain, B. [~N~ln~, C L, Cuf1~/'tow~ff 
Um~rr~y Hos/~a/, ~ DC USA 
The 8t.,nm~l benoffi Of t~ta.tdockof (/t/]) therapy m AMI (t! wtttt ¢~¢ument(~, 
The ~ C~rd~,~mc~la~ P  ~ = ~ Cam Ftr~m~ Ag~'V 
profe~ w~ • goal of mp~d~ q~a~y of cam m Mee~em i~ w~ AMI, 
We evalual~ Ihe OELMARVA ~ data Ht to d~4mmm~ ¢,,;.-~-~ m 
8uevlv01 from tttl IhemlPy ~ n  Whit~ ~ ~ tAe¢~em ~ wflh AMI. MI 
wa~ eo~em.e¢l by 2/"3 ot I~  ~lmv~ng:, ~ ,  c~rr.t~; m,,.Wm~, m'~t EC, G. 
Pelmnts leu  l~an 65 W~l) ~,hJck)d from imllyt~, Th(leb were 1 ~9,0~ pta, 
t44~ Whrk~ (W). 90~ Otactm (O). M~m ~:  W =/5  :t 1,4, O ; "/5,3 
• 7,4, O h4~ morn m~k ta¢1om tar CAD: HTN in O ,. 7194 (79,09%) ~ W 
= 87132 (80,41%) p ,~ 0.0001; ~ B '= 1043 (18,06%) Vt W '~ 2131~ 
(14.11~t%) p < 00001; Rn¢l 0M B ~ ~ (42,1%) v~ W = 4240? (20.4%). p 
0 .~1.  Sligi~y ~ wt~lo pls were II'eate4 with ~l/147.2% vii 44,3% (p .~ 
0.0001) e~uem0 I~e ~x h0~l~¢~lmn, Sun,wai at each tm~e ~r~e~d was 
e,gt~cantty ~ w~ eu~! wm~/~p t~mmy (p .,: 0.0ool): 
e monms 12~ 24 momt~ 
Whnes 
/~# g2% 00% 
No , .  68% ~2% 58% 
Backs 
No-rp ~ 66% SIP= 
~ Smilax s,,.~'~wal be,,~¢i wes ,~,~,k~ from tP, e Im~mem ot 
• Outcomu an~ ~ k m  .~mocbCld Wlth Ua  
comm,~ Imm~m.llo,~ 
CL L_~core, R.V Trask, GJ. I ~  RJ._ Kacch, KJ. Flocha-Singh, 
H.W. Moses, FL  Mkeil, MF_ Shellon, FLW. Ligon. Prame CaMo~lscu/ar 
C~ams.  L~, ~ mx~s. USA 
To evahJate the effects of abcmmam on e;,~,~,y pastures, outcomes and cosls 
of ~ co.-¢.-,~,-./~:x-,s h'om 1/96-6/97 were as~m~md fm I1~ee 
groups: I=age >70wdPn abcmmab Rx; II = age _>70 wllbOut abcmimab Rx; 
III = acj~ <_69 ~t l l  ~¢~lab  Rx. 
Groc, p I II III 
Age yt' x ~SO ( ramge ) 76¢5(70-91) 76 ¢ 5 (70--g3) 57 ± 9 (24-69).1 
N= 309 622 593 
Deem% 16 23 0,3" 
P.e-PTCA % 03 03 0,3 
~ %  10 15 07 
C~T,~,,~te % 32 47 19" 
Bfc, edmg % 26 I 6 02 .1 
LOS day 4 0 44 32 "1 
Hasp Cost $11 666 S9954 t S10,668 
Cu~voos, fe = 0¢,a111 .~ I~ ,, Fle-PTCA + CABG; "p - 001 v.~. geoulp I1; tp • 001 vl~ 0mop 
I 
Logfsllc m ~  ide~tfmd muflTvessei CAD (~ rabo [OR] 3.5. 95% 
CI: 14-102), female gender (OR 3.3. CI 1.3-8.1). and SVG mlet~ 
(OR 3.7, CI 1.3-10.7) as I:~edtctors of adverse events in pa1~lts mceMng 
ab~xm~b dunng hospC~zatmn (p < 0O2) Beedmg was greatm m be~ 
groups of eldedy pat~s  comCmrsd to yo~-C,e,- pabents, but was rmt related 
slgnif~:antty to abaximab Rx. Thus. use of abdxlmab in elderly pu~.~ 
is assoc~ted w~th hospdal costs samilar to ymmger patm~s and excellent 
outcomes. 
Conclusion: 1. Use of a critical pathway was assooated with high adher- 
ence to most quality indicators across all ages. 
2. Lower use of LPA and OR in the eldedy may reflect physician uncertainty 
as to their benefit in this cohort and deserves fudher study. 
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